Relmada Therapeutics to Present at the 2014 Bio International Convention
Relmada Therapeutics, which currently conducts its operations through Camp Nine, Inc. (the "Company"), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that Sergio Traversa, Chief Executive Officer, will be presenting at the 2014 BIO International Convention on Thursday, June 26, at 9:30 AM. PDT. The presentation will take place in the Solana Beach room. Hosted by the Biotechnology Industry Organization (BIO), this year's global event for biotechnology will take place June 23-26 at the...
View full press release